secwatch / observer
8-K filed August 19, 2021, 7:59 PM ET ticker GNSS CIK 0000924383
leadership confidence high sentiment positive materiality 0.35

Genasys appoints Susan Lee and Caltha Seymour to Board of Directors

Genasys Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Susan Lee

Director
GNSS · Genasys Inc.
Effective
2021-09-01
Filed
August 19, 2021, 7:59 PM ET
On August 18, 2021, Genasys Inc. (the “Company”) announced the appointment of Susan Lee and Caltha Seymour to the Board of Directors (the “Board”) of the Company effective September 1, 2021
Appointed

Caltha Seymour

Director
GNSS · Genasys Inc.
Effective
2021-09-01
Filed
August 19, 2021, 7:59 PM ET
On August 18, 2021, Genasys Inc. (the “Company”) announced the appointment of Susan Lee and Caltha Seymour to the Board of Directors (the “Board”) of the Company effective September 1, 2021

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Susan Lee was appointed as Director at Genasys Inc..

Action
appointed
Role
Director
Exact text from the filing
On August 18, 2021, Genasys Inc. (the “Company”) announced the appointment of Susan Lee and Caltha Seymour to the Board of Directors (the “Board”) of the Company effective September 1, 2021
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Caltha Seymour was appointed as Director at Genasys Inc..

Action
appointed
Role
Director
Exact text from the filing
On August 18, 2021, Genasys Inc. (the “Company”) announced the appointment of Susan Lee and Caltha Seymour to the Board of Directors (the “Board”) of the Company effective September 1, 2021
View on SEC.gov

Genasys Inc. filing history →

Source: SEC EDGAR
accession 0001437749-21-020456
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.